Kuftive-DX Syrup is a combination pharmaceutical formulation containing Chlorpheniramine Maleate 4 mg and Dextromethorphan Hydrobromide 10 mg per dose, indicated for the symptomatic relief of cough and allergic conditions associated with upper respiratory tract infections. Chlorpheniramine Maleate is a first-generation antihistamine that exerts its effect by competitively antagonizing H1 histamine receptors, thereby reducing allergic manifestations such as rhinorrhea, sneezing, and itching. Dextromethorphan Hydrobromide acts centrally on the medullary cough center to suppress the cough reflex without causing significant sedation or respiratory depression. Kuftive-DX Syrup is particularly useful in managing dry, non-productive cough accompanied by allergic symptoms. It is recommended for use in adults and children above the age specified in the product guidelines, with dosing adjusted accordingly. Caution is advised in patients with a history of hypersensitivity to either component, respiratory conditions such as asthma, or concurrent use of monoamine oxidase inhibitors (MAOIs). Common adverse effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Kuftive-DX Syrup should be used under medical supervision, and patients are advised to adhere strictly to the prescribed dosage to avoid potential toxicity or drug interactions.